|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 399.2 SEK | +0.45% |
|
+0.81% | +38.90% |
| May. 08 | Mycronic AB Approves Dividend, Payable on May 16, 2024 | CI |
| Apr. 30 | Mycronic AB Receives Order for Two SLX Mask Writers | CI |
Mycronic AB (publ) reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was SEK 4,635 million compared to SEK 3,882 million a year ago. Net income was SEK 827 million compared to SEK 703 million a year ago.
Basic earnings per share from continuing operations was SEK 8.48 compared to SEK 7.1 a year ago. Diluted earnings per share from continuing operations was SEK 8.48 compared to SEK 7.1 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +38.90% | 3.58B | |
| +23.32% | 362B | |
| +15.61% | 118B | |
| +36.96% | 103B | |
| +10.37% | 19.72B | |
| +8.13% | 19.42B | |
| +47.41% | 10.92B | |
| +27.49% | 9.71B | |
| -1.59% | 8.05B | |
| -26.63% | 5.88B |
MYCRONIC AB 
